Send to

Choose Destination
Hematol Oncol Clin North Am. 1995 Apr;9(2):431-50.

O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance.

Author information

Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.


The DNA repair protein, O6-alkylguanine DNA alkyltransferase, is a major contributor to the resistance to the nitrosourea, triazine, and tetrazine class of alkylating agents. Many tumor cells and primary tumor samples contain high levels of this protein, although a great deal of heterogeneity exists between and within tumors. Inhibition of the alkyl-transferase by O6-benzylguanine results in significant potentiation of the cytotoxic effects of these chemotherapeutic agents, generating responses in human tumor xenografts that are completely resistant to nitrosoureas alone. These studies may rekindle the interest in the nitrosourea class of alkylating agents and stimulate the search for inhibitors of other mechanisms of chemotherapy resistance.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center